Announcement under Regulation 30 (LODR)-Press Release / Media Release
30-Mar-2026 | Source : BSEPursuant to Regulation 30 of Listing Regulations please find enclosed Press Release- Wockhardts Zaynich (Zidebactam/ Cefepime) Receives Favourable Recommendation from CDSCOs Subject Expert Committee for Treatment of Gram- Negative Infections.
Closure of Trading Window
25-Mar-2026 | Source : BSEThis is to inform you that pursuant to Companys Code of Conduct for Regulating Monitoring and Reporting trading by Designated Persons the Trading Window for dealing in equity shares of the Company will be closed from 1st April 2026 until 48 (Forty-eight) hours after the declaration of Audited Financial Results of the Company for the financial year ending 31st March 2026.
Announcement under Regulation 30 (LODR)-Newspaper Publication
20-Feb-2026 | Source : BSEPursuant to Regulation 30 read with Schedule III Part A Para A of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 we enclose herewith a copy of the newspaper advertisement published today i.e 20th February 2026 in accordance with the SEBI circular no: HO/38/13/11 (2)2026- MIRSD-POD/1/3750/2026 dated 30th January 2026 regarding the opening of special window for lodgment of the transfer request of shares held in physical form.
Corporate Actions
No Upcoming Board Meetings
Wockhardt Ltd has declared 200% dividend, ex-date: 17 Nov 16
No Splits history available
No Bonus history available
Wockhardt Ltd has announced 3:10 rights issue, ex-date: 08 Mar 22